Your browser doesn't support javascript.
loading
Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design.
Kumar, Anita; Casulo, Carla; Joffe, Erel; Moskowitz, Craig; Gerecitano, John; Moskowitz, Alison; Younes, Anas; Drullinsky, Pamela; Drill, Esther; Choma, Morgan; Grieve, Clare; Joseph, Ashlee; Laraque, Leana; Schick, Dylan; Zelenetz, Andrew; Hamlin, Paul.
Afiliação
  • Kumar A; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Casulo C; Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, United States.
  • Joffe E; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Gerecitano J; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Moskowitz A; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Younes A; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Drullinsky P; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Drill E; Epidemiology and Biostatistics, Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Choma M; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Grieve C; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Joseph A; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Laraque L; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Schick D; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Zelenetz A; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
  • Hamlin P; Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, United States.
Leuk Lymphoma ; 63(12): 2889-2896, 2022 12.
Article em En | MEDLINE | ID: mdl-35972020
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos